With deals in tow, Roche ends 2019 with five discarded programs
With sales coming in just shy of Wall Street estimates and profit that just beat expectations, Roche capped off 2019 on a high having finally …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
